Confusion over Russia's EU vaccine approval bid could be result of misdirected application

Reuters

20 February 2021 - Russia’s submission of its Sputnik V vaccine for approval by the European Union’s medicines regulator appears to have been sent to the wrong agency, according to a Russian document and a clarification of the application process by the regulator.

Russia’s RDIF sovereign wealth fund, which is responsible for marketing the vaccine abroad, has been in a dispute with the EMA in recent weeks over whether the shot had been submitted for approval or not.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Vaccine , Dossier , Russia , COVID-19